Mc1 can improve apoptosis and insulin sensitivity, realizing the comprehensive improvement of NAFLD across pathological links, which has more clinical potentials than the herbs with a single mechanism of action (Roh et al., 2020). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.